BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papaconstantinou D, Vretakakou K, Paspala A, Misiakos EP, Charalampopoulos A, Nastos C, Patapis P, Pikoulis E. The impact of preoperative sarcopenia on postoperative complications following esophagectomy for esophageal neoplasia: a systematic review and meta-analysis. Dis Esophagus 2020:doaa002. [PMID: 32193528 DOI: 10.1093/dote/doaa002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lidoriki I, Mylonas KS, Syllaios A, Vergadis C, Stratigopoulou P, Marinos G, Mastoraki A, Karavokyros I, Schizas D. The Impact of Nutritional and Functional Status on Postoperative Outcomes following Esophageal Cancer Surgery. Nutrition and Cancer. [DOI: 10.1080/01635581.2022.2036769] [Reference Citation Analysis]
2 Yoshida N, Sasaki K, Kanetaka K, Kimura Y, Shibata T, Ikenoue M, Nakashima Y, Sadanaga N, Eto K, Tsuruda Y, Kobayashi S, Nakanoko T, Suzuki K, Takeno S, Yamamoto M, Morita M, Toh Y, Baba H. High Pretreatment Mean Corpuscular Volume Can Predict Worse Prognosis in Patients With Esophageal Squamous Cell Carcinoma who Have Undergone Curative Esophagectomy: A Retrospective Multicenter Cohort Study. Annals of Surgery Open 2022;3:e165. [DOI: 10.1097/as9.0000000000000165] [Reference Citation Analysis]
3 West MA, Baker WC, Rahman S, Munro A, Jack S, Grocott MP, Underwood TJ, Levett DZ; Fit-4-Surgery Consortium. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection. J Surg Oncol 2021. [PMID: 34463378 DOI: 10.1002/jso.26652] [Reference Citation Analysis]
4 Carvalho ALM, Gonzalez MC, Sousa IM, das Virgens IPA, Medeiros GOC, Oliveira MN, Dantas JCAS, Trussardi Fayh AP. Low skeletal muscle radiodensity is the best predictor for short-term major surgical complications in gastrointestinal surgical cancer: A cohort study. PLoS One 2021;16:e0247322. [PMID: 33606786 DOI: 10.1371/journal.pone.0247322] [Reference Citation Analysis]
5 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
6 Mayanagi S, Ishikawa A, Matsui K, Matsuda S, Irino T, Nakamura R, Fukuda K, Wada N, Kawakubo H, Hijikata N, Ando M, Tsuji T, Kitagawa Y. Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer. Dis Esophagus 2021;34:doaa121. [PMID: 33306782 DOI: 10.1093/dote/doaa121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Voorn M, Beukers K, Trepels C, Bootsma G, Bongers B, Janssen-heijnen M. Associations between pretreatment nutritional assessments and treatment complications in patients with stage I-III non-small cell lung cancer: A systematic review. Clinical Nutrition ESPEN 2022;47:152-62. [DOI: 10.1016/j.clnesp.2021.12.026] [Reference Citation Analysis]
8 Zhang Y, Weng S, Huang L, Shen X, Zhao F, Yan S. Association of sarcopenia with a higher risk of infection in patients with type 2 diabetes. Diabetes Metab Res Rev 2021;:e3478. [PMID: 34041847 DOI: 10.1002/dmrr.3478] [Reference Citation Analysis]
9 Zouhry Y, Taibi A, Durand-Fontanier S, Darbas T, Forestier G, Monteil J, Lebrun-Ly V, Fayemendy P, Leobon S, Jesus P, Deluche E. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence. BMC Cancer 2021;21:1313. [PMID: 34876055 DOI: 10.1186/s12885-021-09037-3] [Reference Citation Analysis]
10 Yoshida N, Horinouchi T, Toihata T, Harada K, Eto K, Sawayama H, Iwatsuki M, Nagai Y, Ishimoto T, Baba Y, Miyamoto Y, Baba H. Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study. Ann Surg Oncol 2021. [PMID: 34467503 DOI: 10.1245/s10434-021-10719-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int 2021;45:273-86. [PMID: 33236822 DOI: 10.1002/cbin.11506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yoshida S, Nishigori T, Tsunoda S, Tanaka E, Okabe H, Kobayashi A, Nobori Y, Obama K, Hisamori S, Shide K, Inagaki N, Sakai Y. Chronological Changes in Skeletal Muscle Mass Two Years after Minimally Invasive Esophagectomy: A Prospective Cohort Study. Surg Endosc 2021. [PMID: 33755788 DOI: 10.1007/s00464-021-08440-y] [Reference Citation Analysis]
13 Chen F, Chi J, Zhao B, Mei F, Gao Q, Zhao L, Ma B. Impact of preoperative sarcopenia on postoperative complications and survival outcomes of patients with esophageal cancer: a meta-analysis of cohort studies. Dis Esophagus 2022:doab100. [PMID: 35077542 DOI: 10.1093/dote/doab100] [Reference Citation Analysis]
14 Grün J, Elfinger L, Le H, Weiß C, Otto M, Reißfelder C, Blank S. The Influence of Pretherapeutic and Preoperative Sarcopenia on Short-Term Outcome after Esophagectomy. Cancers (Basel) 2020;12:E3409. [PMID: 33213090 DOI: 10.3390/cancers12113409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]